Literature DB >> 11156734

Dosage, pharmacological effects and clinical outcomes for bivalirudin in percutaneous coronary intervention.

H K Lui1.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 11156734

Source DB:  PubMed          Journal:  J Invasive Cardiol        ISSN: 1042-3931            Impact factor:   2.022


× No keyword cloud information.
  3 in total

Review 1.  Bivalirudin: a review of its potential place in the management of acute coronary syndromes.

Authors:  Christopher I Carswell; Greg L Plosker
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Effect of body mass index on Argatroban therapy during percutaneous coronary intervention.

Authors:  Marcie J Hursting; Ik-Kyung Jang
Journal:  J Thromb Thrombolysis       Date:  2007-05-28       Impact factor: 2.300

Review 3.  New Approaches to the Role of Thrombin in Acute Coronary Syndromes: Quo Vadis Bivalirudin, a Direct Thrombin Inhibitor?

Authors:  María Asunción Esteve-Pastor; Diana Hernández-Romero; Mariano Valdés; Francisco Marín
Journal:  Molecules       Date:  2016-02-27       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.